Prediction of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer by using a deep learning model with 18F-FDG PET/CT

被引:2
|
作者
Bulut, Gulcan [1 ]
Atilgan, Hasan Ikbal [2 ]
Cinarer, Gokalp [3 ]
Kilic, Kazim [4 ]
Yikar, Deniz [5 ]
Parlar, Tuba [6 ]
机构
[1] Int Med Hosp, Div Med Oncol, Izmir, Turkiye
[2] Mustafa Kemal Univ, Med Sch, Dept Nucl Med, Hatay, Turkiye
[3] Bozok Univ, Fac Engn & Architecture, Dept Comp Engn, Yozgat, Turkiye
[4] Bozok Univ, Yozgat Vocat High Sch, Dept Comp Programming, Yozgat, Turkiye
[5] Hatay Training & Res Hosp, Div Nucl Med, Hatay, Turkiye
[6] Mustafa Kemal Univ, Dept Comp Technol, Hatay, Turkiye
来源
PLOS ONE | 2023年 / 18卷 / 09期
关键词
LYMPH-NODE METASTASIS; SURVIVAL;
D O I
10.1371/journal.pone.0290543
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
ObjectivesThe aim of the study is 18F-FDG PET/CT imaging by using deep learning method are predictive for pathological complete response pCR after Neoadjuvant chemotherapy (NAC) in locally advanced breast cancer (LABC).IntroductionNAC is the standard treatment for locally advanced breast cancer (LABC). Pathological complete response (pCR) after NAC is considered a good predictor of disease-free survival (DFS) and overall survival (OS).Therefore, there is a need to develop methods that can predict the pCR at the time of diagnosis.MethodsThis article was designed as a retrospective chart study.For the convolutional neural network model, a total of 355 PET/CT images of 31 patients were used. All patients had primary breast surgery after completing NAC.ResultsPathological complete response was obtained in a total of 9 patients. The study results show that our proposed deep convolutional neural networks model achieved a remarkable success with an accuracy of 84.79% to predict pathological complete response.ConclusionIt was concluded that deep learning methods can predict breast cancer treatment.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Staging of locally advanced breast cancer and the prediction of response to neoadjuvant chemotherapy: complementary role of scintimammography and 18F-FDG PET/CT
    Evangelista, Laura
    Cervino, Anna R.
    Michieletto, Silvia
    Saibene, Tania
    Orvieto, Enrico
    Bozza, Fernando
    Ghiotto, Cristina
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 61 (02): : 205 - 215
  • [2] 18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer
    Joan Duch
    David Fuster
    Montserrat Muñoz
    Pedro Luís Fernández
    Pilar Paredes
    Montserrat Fontanillas
    Flavia Guzmán
    Sebastià Rubí
    Francisco Juan Lomeña
    Francesca Pons
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36 : 1551 - 1557
  • [3] 18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer
    Duch, Joan
    Fuster, David
    Munoz, Montserrat
    Luis Fernandez, Pedro
    Paredes, Pilar
    Fontanillas, Montserrat
    Guzman, Flavia
    Rubi, Sebastia
    Juan Lomena, Francisco
    Pons, Francesca
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (10) : 1551 - 1557
  • [4] Sequential 18F-FDG PET/CT for early prediction of complete pathological response in breast and axilla during neoadjuvant chemotherapy
    Koolen, Bas B.
    Pengel, Kenneth E.
    Wesseling, Jelle
    Vogel, Wouter V.
    Peeters, Marie-Jeanne T. F. D. Vrancken
    Vincent, Andrew D.
    Gilhuijs, Kenneth G. A.
    Rodenhuis, Sjoerd
    Rutgers, Emiel J. Th.
    Olmos, Renato A. Valdes
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (01) : 32 - 40
  • [5] Sequential 18F-FDG PET/CT for early prediction of complete pathological response in breast and axilla during neoadjuvant chemotherapy
    Bas B. Koolen
    Kenneth E. Pengel
    Jelle Wesseling
    Wouter V. Vogel
    Marie-Jeanne T. F. D. Vrancken Peeters
    Andrew D. Vincent
    Kenneth G. A. Gilhuijs
    Sjoerd Rodenhuis
    Emiel J. Th. Rutgers
    Renato A. Valdés Olmos
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 32 - 40
  • [6] Utility of 18F-FDG PET/CT for the prediction of pathologic complete response in axilla to neoadjuvant chemotherapy in breast cancer
    Michel, Eloise
    Beltjens, Francoise
    Cochet, Alexandre
    Alberini, Jean Louis
    Coutant, Charles
    Jankowski, Clementine
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [7] 18F-FDG PET/CT for early prediction of pathological complete response in breast cancer neoadjuvant therapy: a retrospective analysis
    Wu, Yilin
    Li, Yanling
    Chen, Bin
    Zhang, Ying
    Xing, Wanying
    Guo, Baoliang
    Wang, Wan
    [J]. ONCOLOGIST, 2024,
  • [8] The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
    Amandeep Kumar
    Rakesh Kumar
    Vathalaru Seenu
    Sidharatha Datta Gupta
    Madhavi Chawla
    Arun Malhotra
    Sada Nand Mehta
    [J]. European Radiology, 2009, 19 : 1347 - 1357
  • [9] The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
    Kumar, Amandeep
    Kumar, Rakesh
    Seenu, Vathalaru
    Gupta, Sidharatha Datta
    Chawla, Madhavi
    Malhotra, Arun
    Mehta, Sada Nand
    [J]. EUROPEAN RADIOLOGY, 2009, 19 (06) : 1347 - 1357
  • [10] The Value of 18F-FDG PET/CT Imaging in the Evaluation of Interim Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer
    Tatar, Gamze
    Ozkul, Ozlem
    Alcin, Goksel
    [J]. MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2022, 31 (02) : 123 - 129